Rituximab Correction | The Medical Letter Inc.

The Medical Letter on Drugs and Therapeutics

FROM
ISSUE

1031

July 17, 1998

View Complete Issue Table of Contents 2019

Rituximab Correction

View Complete Issue

Send Article Feedback

Med Lett Drugs Ther. 1998 Jul 17;40(1031):74

Disclosures

Objective(s)

SUMMARY: In the Medical Letter article on rituximab (Rituxan - vol 40, page 66, June 19, 1998), the second sentence in the paragraph on Dosage and Cost should say that the rate of infusion can slowly be increased to a maximum of 400 mg/hour.

The Medical Letter, Inc. does not warrant that all the material in this publication is accurate and complete in every respect. The Medical Letter, Inc. and its editors shall not be held responsible for any damage resulting from any error, inaccuracy, or omission.

This article has been freely provided.